Programming renal biopsy in postoperative monitor of renal transplantation

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-DDT-08000259

Enrollment

Unknown

Registered

2008-12-16

Start date

2009-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal transplantation

Interventions

Gold Standard:

Index test:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Allograft renal transplantation receptor without age and sex limit; 2. Willing to sign informed consent and in good compliance; 3. No contradiction of renal biopsy including: severe disturbances of blood coagulation, periphery infection of transplanted kidney, large periphery hematoma surrounding graft, hydronephrosis in graft, severe hypertension, severe anemia and severe azotemia.

Exclusion criteria

Exclusion criteria: Patients with a psychiatric disorders history or other disease that interfere understanding of the requirements of study.

Design outcomes

Primary

Measure	Time frame
Pathological Banff grading;Survival rate of transplanted kidney;	—

Secondary

Measure	Time frame
Concentration of serum creatinine;Tolerance of renal biopsy;Rate of Complications;	—

Countries

China

Contacts

Public ContactLizhong Chen

clz@medmail.com.cn+86 13902303569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026